EN
HI
Sandu Pharmaceuticals Chart
Sandu Pharmaceuticals Share Key Metrics
Volume
3233.00
Market Cap
37.70 CR
LTQ@LTP
100@38.45
ATP
38.58
Var Margin
25 %
Circuit Range
31.22-46.82
Delivery %
100 %
Value
1.25 L
ASM/GSM
No
Market Lot
1
Summary
Sandu Pharmaceuticals share price stands at ₹38.45 at 12 May, 2026 | 15:24. The stock Sandu Pharmaceuticals intraday movement has stayed between ₹37.01 and ₹39.02, while on a 52-week basis it has fluctuated from ₹30.00 to ₹58.80.
In terms of trading activity, Sandu Pharmaceuticals has recorded a volume of 3233 shares. The Sandu Pharmaceuticals has a market cap of ₹9660990. The stock’s Average Traded Price (ATP) stands at ₹3858, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100, 3845.
The Sandu Pharmaceuticals operates within a circuit range of ₹31.22-46.82 – ₹31.22-46.82, with a Value of ₹1.25 L. The Delivery Percentage for the day is 100%. Additionally, Sandu Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Sandu Pharmaceuticals Fundamentals
View MoreP/E Ratio
24.29
P/B Ratio
1.13
Div. Yield
2.56
Sector P/E
68.8
Sector P/B
3.58
Sec. Div. Yield
0.56
Sandu Pharmaceuticals Resistance and Support
Pivot 39.24
Resistance
First Resistance
39.48
Second Resistance
39.94
Third Resistance
40.18
Support
First Support
38.78
Second Support
38.54
Third Support
38.08
Sandu Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-10-14 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
Sandu Pharmaceuticals News
Sandu Pharmaceuticals Ltd - 524703 - Corporate Action-Board approves Dividend
Sandu Pharma board recommended ₹1 per equity share dividend for FY26, subject to shareholder approval. Record and payout dates will be intimated later.
May 05 2026 18:05:00
Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 05Th May 2026
Sandu Pharmaceuticals' board approved Q4 FY26 standalone financial results, showing a profit of ₹4.34 lakhs (down 86.7% YoY). A final dividend of ₹1 per share for FY26 was recommended, and cost & internal auditors were reappointed for FY27.
May 05 2026 18:05:00
Read More
About Sandu Pharmaceuticals
NSE : 0
BSE : 524703
ISIN : INE751D01014
Sandu Pharmaceuticals Management
| Name | Position |
|---|---|
| Balram Viswanathan | Non Executive Independent Director |
| Ajit R Kantak | Non Executive Independent Director |
Sandu Pharmaceuticals FAQs
The Buying Price of Sandu Pharmaceuticals share is 38.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sandu Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sandu Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sandu Pharmaceuticals shares is 24.29. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sandu Pharmaceuticals shares is 1.13. Useful to assess the stock's value relative to its book value.
To assess Sandu Pharmaceuticals’s valuation compare Sector P/E, P/B which are 68.8 & 3.58 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sandu Pharmaceuticals is 37.70 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sandu Pharmaceuticals share price is 58.80 & 30.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sandu Pharmaceuticals belongs to the Healthcare sector.
